Trial Profile
Botulinum Toxin is a Potential Prophylactic Therapy for Minimizing Post-excisional Scarring: A Double Blinded, Randomized Controlled Trial
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Apr 2021
Price :
$35
*
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Scars
- Focus Therapeutic Use
- Acronyms Allergan Botox Scar Study
- 10 Apr 2021 Primary endpoint has been met. (Modified Manchester Scar Scale (MMSS) Score), as per Results published in the Journal of the American Academy of Dermatology
- 10 Apr 2021 Results published in the Journal of the American Academy of Dermatology
- 18 Apr 2019 Status changed from recruiting to completed.